NOTES FROM
THE PHARMACEUTICAL INDUSTRY


According to free market and hospital overall IQVIA data*, 2,414 million units and TL 52.3 billion (*) worth of medicines were sold in Turkish pharmaceutical market in 2020. The market underwent a downsizing of 5.2% in number of units and at a rate of 19.4% increase in TL compared to the previous year.

Rate of prescription drugs to total pharmaceutical market in Turkish market is 96.1% in number of units and 94.4% in TL.

Although drugs from many treatment groups are imported in our country, preparations requiring new and advanced technology, anti-cancer medicines, blood factors, nervous system drugs, insulin, and some controlled-release drugs are predominantly imported.

According to IQVIA data, the sector’s import grew by 4.8% on a unit basis and increased by 1.7% on a USD basis, resulting in USD 3.9 billion in 2020. The domestic pharmaceutical market shrank by 7.2% on a unit basis and by 7.3% on a USD basis, resulting in 3.6 billion USD. The rate of imports in the total market is 18.5% on a unit basis and 52.0% on a USD basis.

According to IQVIA data, the sector shrank by 5.2% on a unit basis and by 2.8% on a USD basis, resulting in USD 7.5 billion in 2020. The total pharmaceutical market reached TL 52.3 billion, with a growth of 19.4%.

 

 

Source: IQVIA Free + Hospital Data View